70 results for “Amgen”
Medicine Active substance Licence holder Status
Otezla 10 mg film-coated tablets Otezla 20 mg film-coated tablets Otezla 30 mg film-coated tablets EU/1/14/981/001
Apremilast, Apremilast, Apremilast
Amgen Europe B.V.,
—
Otezla 20 mg film–coated tablets EU/1/14/981/005
Apremilast
Amgen Europe B.V.,
—
Otezla 30 mg film-coated tablets EU/1/14/981/002-003
Apremilast
Amgen Europe B.V.,
—
Parsabiv 10 mg solution for injection EU/1/16/1142/009-012
Etelcalcetide hydrochloride
Amgen Europe B.V.,
—
Parsabiv 2.5 mg solution for injection EU/1/16/1142/001-004
Etelcalcetide hydrochloride
Amgen Europe B.V.,
—
Parsabiv 5 mg solution for injection EU/1/16/1142/005-008
Etelcalcetide hydrochloride
Amgen Europe B.V.,
—
PAVBLU 40 mg/mL solution for injection in a vial EU/1/25/1909/002
Aflibercept
Amgen Technology (Ireland) Unlimited Company
—
PAVBLU 40 mg/mL solution for injection in pre-filled syringe EU/1/25/1909/001
Aflibercept
Amgen Technology (Ireland) Unlimited Company
—
Prolia 60 mg solution for injection in pre-filled syringe EU/1/10/618/1-4
Denosumab
Amgen Europe B.V.,
—
Repatha 140 mg solution for injection in pre-filled pen EU/1/15/1016/002-005
Evolocumab
Amgen Europe B.V.
—
Repatha 140 mg solution for injection in pre-filled syringe EU/1/15/1016/001
Evolocumab
Amgen Europe B.V.,
—
Repatha 420 mg solution for injection in cartridge EU/1/15/1016/006-007
Evolocumab
Amgen Europe B.V.
—
TEPEZZA 500 mg powder for concentrate for solution for infusion EU/1/25/1941/001
Teprotumumab
Amgen Europe B.V.,
—
Uplizna 100 mg concentrate for solution for infusion EU/1/21/1602/001
Inebilizumab
Amgen Europe B.V.,
—
Vectibix 20 mg/mL concentrate for solution for infusion EU/1/07/423/001-003
Panitumumab
Amgen Europe B.V.,
—
WEZENLA 130 mg Concentrate for solution for infusion EU/1/24/1823/004
Ustekinumab
Amgen Technology (Ireland) UC
—
WEZENLA 45 mg Solution for injection EU/1/24/1823/001
Ustekinumab
Amgen Technology (Ireland) UC
—
WEZENLA 45 mg Solution for injection pre-filled syringe EU/1/24/1823/002
Ustekinumab
Amgen Technology (Ireland) UC
—
WEZENLA 90 mg Solution for injection pre-filled syringe EU/1/24/1823/003
Ustekinumab
Amgen Technology (Ireland) UC
—
XGEVA 120 mg solution for injection EU/1/11/703/001-002
Denosumab
Amgen Europe B.V.,
—
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy .
Essential only
Accept all